Contact
searchSearch
HMP Global

Oncology Learning Network NP/PA Institute

Featured

Holly Stewart, PA-C
Videos
Managing Emotional Care Challenges in Cancer Treatment
03/12/2026
Holly Stewart, PA-C, presents a discussion on tips and strategies for navigating emotional care challenges across the cancer journey, including monitoring moods and habits and utilizing the SPIKES protocol.
Holly Stewart, PA-C, presents a discussion on tips and strategies for navigating emotional care challenges across the cancer journey, including monitoring moods and habits and utilizing the SPIKES protocol.
Holly Stewart, PA-C, presents a...
03/12/2026
Oncology Learning Network NP/PA Institute
Jennie Goble, DMSc, PA-C
Videos
Highlighting New Treatments and Strategies for Acute Myeloid Leukemia and Acute Lymphocytic Leukemia
02/27/2026
Jennie Goble, DMSc, PA-C
Jennie Goble, DMSc, PA-C, reviews advances in AML and ALL, highlighting molecularly targeted therapies, MRD-guided care, and expanding use of immunotherapy aimed at improving outcomes while minimizing toxicity.
Jennie Goble, DMSc, PA-C, reviews advances in AML and ALL, highlighting molecularly targeted therapies, MRD-guided care, and expanding use of immunotherapy aimed at improving outcomes while minimizing toxicity.
Jennie Goble, DMSc, PA-C,...
02/27/2026
Oncology Learning Network NP/PA Institute
Andrew Lin, PharmD
Conference Coverage
Exploring Clinical Approaches to Managing CAR-T and Bispecific Therapy Toxicities
02/17/2026
Andrew Lin, PharmD, reviewed practical strategies for managing cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and cytopenias associated with CAR T-cell and bispecific therapies.
Andrew Lin, PharmD, reviewed practical strategies for managing cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and cytopenias associated with CAR T-cell and bispecific therapies.
Andrew Lin, PharmD, reviewed...
02/17/2026
Oncology Learning Network NP/PA Institute
Donna Catamero, ANP-BC, OCN, CCRC
Conference Coverage
Exploring the Rapidly Evolving Landscape of Targeted Therapy for Multiple Myeloma
02/11/2026
Donna Catamero, ANP-BC, OCN, CCRC
Donna Catamero, ANP-BC, OCN, CCRC, highlighted the rapidly evolving multiple myeloma treatment landscape, with quadruplet therapy now standard in newly diagnosed disease, earlier use of CAR-T therapy in relapse, and emerging bispecific and...
Donna Catamero, ANP-BC, OCN, CCRC, highlighted the rapidly evolving multiple myeloma treatment landscape, with quadruplet therapy now standard in newly diagnosed disease, earlier use of CAR-T therapy in relapse, and emerging bispecific and...
Donna Catamero, ANP-BC, OCN,...
02/11/2026
Oncology Learning Network NP/PA Institute
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Conference Coverage
Clinical Strategies for the Assessment and Management of Antibody-Drug Conjugate Toxicities
01/30/2026
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C,...
01/30/2026
Oncology Learning Network NP/PA Institute
Jessica Walchonski, PA-C, MMS
Conference Coverage
Exploring Key Advances and Emerging Therapies in Gynecologic Oncology
01/23/2026
Jessica Walchonski, PA-C, MMS
Jessica Walchonski, PA-C, MMS, reviewed recent advances in gynecologic oncology, highlighting new targeted and immunotherapy options for ovarian cancer and evolving strategies for endometrial cancer at the 2025 Oncology Learning Network APP...
Jessica Walchonski, PA-C, MMS, reviewed recent advances in gynecologic oncology, highlighting new targeted and immunotherapy options for ovarian cancer and evolving strategies for endometrial cancer at the 2025 Oncology Learning Network APP...
Jessica Walchonski, PA-C, MMS,...
01/23/2026
Oncology Learning Network NP/PA Institute
Allison Tanner, PA-C
Conference Coverage
Evolving Toxicity Management Strategies for CAR T-Cell and Bispecific Therapies
01/16/2026
Allison Tanner, PA-C
Allison Tanner, PA-C, reviewed the recognition and management of CRS, ICANS, and other evolving toxicities associated with CAR T-cell therapy and bispecific antibodies, emphasizing the need for clinician readiness as cellular therapies...
Allison Tanner, PA-C, reviewed the recognition and management of CRS, ICANS, and other evolving toxicities associated with CAR T-cell therapy and bispecific antibodies, emphasizing the need for clinician readiness as cellular therapies...
Allison Tanner, PA-C, reviewed...
01/16/2026
Oncology Learning Network NP/PA Institute
Amy Goodrich, RN, BSN, MSN, CRNP-AC
Conference Coverage
Refining Treatment Pathways: Data-Driven Approaches to Sequencing in Lymphoma
01/08/2026
Amy Goodrich, RN, BSN, MSN, CPNP-AC
Amy Goodrich, RN, BSN, MSN, CRNP-AC, reviewed emerging treatments and the growing challenges of therapy sequencing in DLBCL, FL, and CLL, emphasizing individualized approaches guided by patient characteristics and evolving data.
Amy Goodrich, RN, BSN, MSN, CRNP-AC, reviewed emerging treatments and the growing challenges of therapy sequencing in DLBCL, FL, and CLL, emphasizing individualized approaches guided by patient characteristics and evolving data.
Amy Goodrich, RN, BSN, MSN,...
01/08/2026
Oncology Learning Network NP/PA Institute
Beth Sandy, MSN, CRNP, FAPO
Videos
Navigating Toxicities and Monitoring Strategies for Tyrosine Kinase Inhibitor Therapies for Lung and Breast Cancer
01/05/2026
Beth Sandy, MSN, CRNP, FAPO
Beth Sandy, MSN, CRNP, FAPO, reviewed the clinical use and toxicity management of tyrosine kinase inhibitors across solid tumors at the 2025 Oncology Learning Network APP Institute.
Beth Sandy, MSN, CRNP, FAPO, reviewed the clinical use and toxicity management of tyrosine kinase inhibitors across solid tumors at the 2025 Oncology Learning Network APP Institute.
Beth Sandy, MSN, CRNP, FAPO,...
01/05/2026
Oncology Learning Network NP/PA Institute
Kevin Chen, PharmD, MS, BCOP, CPP
Conference Coverage
Evolving Treatment Landscape of New and Novel Therapies for Solid Tumors
12/17/2025
Kevin Chen, PharmD, MS, BCOP
Kevin Chen, PharmD, discussed the increase in recent biomarker-driven drug approvals for solid tumors at the 2025 JADPRO Annual Conference, highlighting their targeted efficacy, unique toxicity profiles, and the need for clinicians to stay up...
Kevin Chen, PharmD, discussed the increase in recent biomarker-driven drug approvals for solid tumors at the 2025 JADPRO Annual Conference, highlighting their targeted efficacy, unique toxicity profiles, and the need for clinicians to stay up...
Kevin Chen, PharmD, discussed...
12/17/2025
Oncology Learning Network NP/PA Institute
Shila Pandey, DNP, AGPCNP-BC, ACHPN, FPCN
Conference Coverage
Development of an APP-Led Quality Assurance Committee to Enhance Patient Safety and Care Quality
12/11/2025
Shila Pandey, DNP, AGPCNP-BC, ACHPN
At the 2025 JADPRO meeting, Shila Pandey, DNP, shared insights into the development of an advanced-practice-provider-led quality assurance committee designed to improve patient safety and care quality.
At the 2025 JADPRO meeting, Shila Pandey, DNP, shared insights into the development of an advanced-practice-provider-led quality assurance committee designed to improve patient safety and care quality.
At the 2025 JADPRO meeting,...
12/11/2025
Oncology Learning Network NP/PA Institute

Rapid Refresh

BCMA
Rapid Refresh
Understanding the Role of BCMA in Cancer Pathogenesis
07/23/2024
This animation explains the role of BCMA in the life cycle of plasma cells and the effects of overexpression of BCMA on the abnormal survival of these cells.
This animation explains the role of BCMA in the life cycle of plasma cells and the effects of overexpression of BCMA on the abnormal survival of these cells.
This animation explains the role...
07/23/2024
Oncology Learning Network NP/PA Institute
BCL2
Rapid Refresh
Understanding the Role of BCL2 in Cancer Pathogenesis
07/23/2024
This animation discusses the role of BCL2 in normal cell function and explains the effects of disruptions in the BCL2 gene on cell signaling.
This animation discusses the role of BCL2 in normal cell function and explains the effects of disruptions in the BCL2 gene on cell signaling.
This animation discusses the...
07/23/2024
Oncology Learning Network NP/PA Institute
ALK
Rapid Refresh
Understanding the Role of ALK in Cancer Pathogenesis
07/23/2024
This animation explains the role of the ALK oncogene in normal cellular functioning and the effect of an abnormal translocation event where ALK fuses to another gene.
This animation explains the role of the ALK oncogene in normal cellular functioning and the effect of an abnormal translocation event where ALK fuses to another gene.
This animation explains the role...
07/23/2024
Oncology Learning Network NP/PA Institute
20S Proteasome
Rapid Refresh
Understanding the Role of 20S Proteasome in Cancer Pathogenesis
07/23/2024
This animation explains the role of the 20S proteasome in regulating the cellular life cycle and the effects of disruptions in the ubiquitin proteasome system.
This animation explains the role of the 20S proteasome in regulating the cellular life cycle and the effects of disruptions in the ubiquitin proteasome system.
This animation explains the role...
07/23/2024
Oncology Learning Network NP/PA Institute
CEACAM5
Rapid Refresh
Understanding the Role of CEACAM5 in Cancer Pathogenesis
07/08/2024
This animation explains the role of the CEACAM5 glycoprotein in the inhibition of cell differentiation and apoptosis, which can promote tumor growth and metastasis.
This animation explains the role of the CEACAM5 glycoprotein in the inhibition of cell differentiation and apoptosis, which can promote tumor growth and metastasis.
This animation explains the role...
07/08/2024
Oncology Learning Network NP/PA Institute
EZH2
Rapid Refresh
Understanding the Role of EZH2 in Cancer Pathogenesis
02/28/2024
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role...
02/28/2024
Oncology Learning Network NP/PA Institute
EGFR
Rapid Refresh
Understanding the Role of EGFR in Cancer Pathogenesis
11/23/2023
This animation explains the role of EGFR in the regulation of cell growth and the effects of the overexpression of EGFR.
This animation explains the role of EGFR in the regulation of cell growth and the effects of the overexpression of EGFR.
This animation explains the role...
11/23/2023
Oncology Learning Network NP/PA Institute
CD19
Rapid Refresh
Understanding the Role of CD19 in Cancer Pathogenesis
11/09/2023
This animation explains the role of the CD19 antigen in the primary signaling complex on the surface of B-cells and the effect of overexpression of this antigen.
This animation explains the role of the CD19 antigen in the primary signaling complex on the surface of B-cells and the effect of overexpression of this antigen.
This animation explains the role...
11/09/2023
Oncology Learning Network NP/PA Institute
BTK
Rapid Refresh
Understanding the Role of BTK in Cancer Pathogenesis
11/09/2023
This animation explains the role of Bruton's tyrosine kinase (BTK) in B-cell development and maturation and the effects of aberrant expression of this oncogene.
This animation explains the role of Bruton's tyrosine kinase (BTK) in B-cell development and maturation and the effects of aberrant expression of this oncogene.
This animation explains the role...
11/09/2023
Oncology Learning Network NP/PA Institute
HER2
Rapid Refresh
Understanding the Role of HER2 in Cancer Pathogenesis
11/08/2023
This animation explains the role of HER2 in the regulation of cell growth and the negative effects of HER2 overexpression.
This animation explains the role of HER2 in the regulation of cell growth and the negative effects of HER2 overexpression.
This animation explains the role...
11/08/2023
Oncology Learning Network NP/PA Institute

APP Perspectives

Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
Oncology Learning Network NP/PA Institute

Meeting Coverage

Holly Stewart, PA-C
Videos
Managing Emotional Care Challenges in Cancer Treatment
03/12/2026
Holly Stewart, PA-C, presents a discussion on tips and strategies for navigating emotional care challenges across the cancer journey, including monitoring moods and habits and utilizing the SPIKES protocol.
Holly Stewart, PA-C, presents a discussion on tips and strategies for navigating emotional care challenges across the cancer journey, including monitoring moods and habits and utilizing the SPIKES protocol.
Holly Stewart, PA-C, presents a...
03/12/2026
Oncology Learning Network NP/PA Institute
Jennie Goble, DMSc, PA-C
Videos
Highlighting New Treatments and Strategies for Acute Myeloid Leukemia and Acute Lymphocytic Leukemia
02/27/2026
Jennie Goble, DMSc, PA-C
Jennie Goble, DMSc, PA-C, reviews advances in AML and ALL, highlighting molecularly targeted therapies, MRD-guided care, and expanding use of immunotherapy aimed at improving outcomes while minimizing toxicity.
Jennie Goble, DMSc, PA-C, reviews advances in AML and ALL, highlighting molecularly targeted therapies, MRD-guided care, and expanding use of immunotherapy aimed at improving outcomes while minimizing toxicity.
Jennie Goble, DMSc, PA-C,...
02/27/2026
Oncology Learning Network NP/PA Institute
Andrew Lin, PharmD
Conference Coverage
Exploring Clinical Approaches to Managing CAR-T and Bispecific Therapy Toxicities
02/17/2026
Andrew Lin, PharmD, reviewed practical strategies for managing cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and cytopenias associated with CAR T-cell and bispecific therapies.
Andrew Lin, PharmD, reviewed practical strategies for managing cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and cytopenias associated with CAR T-cell and bispecific therapies.
Andrew Lin, PharmD, reviewed...
02/17/2026
Oncology Learning Network NP/PA Institute
Donna Catamero, ANP-BC, OCN, CCRC
Conference Coverage
Exploring the Rapidly Evolving Landscape of Targeted Therapy for Multiple Myeloma
02/11/2026
Donna Catamero, ANP-BC, OCN, CCRC
Donna Catamero, ANP-BC, OCN, CCRC, highlighted the rapidly evolving multiple myeloma treatment landscape, with quadruplet therapy now standard in newly diagnosed disease, earlier use of CAR-T therapy in relapse, and emerging bispecific and...
Donna Catamero, ANP-BC, OCN, CCRC, highlighted the rapidly evolving multiple myeloma treatment landscape, with quadruplet therapy now standard in newly diagnosed disease, earlier use of CAR-T therapy in relapse, and emerging bispecific and...
Donna Catamero, ANP-BC, OCN,...
02/11/2026
Oncology Learning Network NP/PA Institute
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Conference Coverage
Clinical Strategies for the Assessment and Management of Antibody-Drug Conjugate Toxicities
01/30/2026
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C,...
01/30/2026
Oncology Learning Network NP/PA Institute
Jessica Walchonski, PA-C, MMS
Conference Coverage
Exploring Key Advances and Emerging Therapies in Gynecologic Oncology
01/23/2026
Jessica Walchonski, PA-C, MMS
Jessica Walchonski, PA-C, MMS, reviewed recent advances in gynecologic oncology, highlighting new targeted and immunotherapy options for ovarian cancer and evolving strategies for endometrial cancer at the 2025 Oncology Learning Network APP...
Jessica Walchonski, PA-C, MMS, reviewed recent advances in gynecologic oncology, highlighting new targeted and immunotherapy options for ovarian cancer and evolving strategies for endometrial cancer at the 2025 Oncology Learning Network APP...
Jessica Walchonski, PA-C, MMS,...
01/23/2026
Oncology Learning Network NP/PA Institute
Allison Tanner, PA-C
Conference Coverage
Evolving Toxicity Management Strategies for CAR T-Cell and Bispecific Therapies
01/16/2026
Allison Tanner, PA-C
Allison Tanner, PA-C, reviewed the recognition and management of CRS, ICANS, and other evolving toxicities associated with CAR T-cell therapy and bispecific antibodies, emphasizing the need for clinician readiness as cellular therapies...
Allison Tanner, PA-C, reviewed the recognition and management of CRS, ICANS, and other evolving toxicities associated with CAR T-cell therapy and bispecific antibodies, emphasizing the need for clinician readiness as cellular therapies...
Allison Tanner, PA-C, reviewed...
01/16/2026
Oncology Learning Network NP/PA Institute
Amy Goodrich, RN, BSN, MSN, CRNP-AC
Conference Coverage
Refining Treatment Pathways: Data-Driven Approaches to Sequencing in Lymphoma
01/08/2026
Amy Goodrich, RN, BSN, MSN, CPNP-AC
Amy Goodrich, RN, BSN, MSN, CRNP-AC, reviewed emerging treatments and the growing challenges of therapy sequencing in DLBCL, FL, and CLL, emphasizing individualized approaches guided by patient characteristics and evolving data.
Amy Goodrich, RN, BSN, MSN, CRNP-AC, reviewed emerging treatments and the growing challenges of therapy sequencing in DLBCL, FL, and CLL, emphasizing individualized approaches guided by patient characteristics and evolving data.
Amy Goodrich, RN, BSN, MSN,...
01/08/2026
Oncology Learning Network NP/PA Institute
Beth Sandy, MSN, CRNP, FAPO
Videos
Navigating Toxicities and Monitoring Strategies for Tyrosine Kinase Inhibitor Therapies for Lung and Breast Cancer
01/05/2026
Beth Sandy, MSN, CRNP, FAPO
Beth Sandy, MSN, CRNP, FAPO, reviewed the clinical use and toxicity management of tyrosine kinase inhibitors across solid tumors at the 2025 Oncology Learning Network APP Institute.
Beth Sandy, MSN, CRNP, FAPO, reviewed the clinical use and toxicity management of tyrosine kinase inhibitors across solid tumors at the 2025 Oncology Learning Network APP Institute.
Beth Sandy, MSN, CRNP, FAPO,...
01/05/2026
Oncology Learning Network NP/PA Institute
Kevin Chen, PharmD, MS, BCOP, CPP
Conference Coverage
Evolving Treatment Landscape of New and Novel Therapies for Solid Tumors
12/17/2025
Kevin Chen, PharmD, MS, BCOP
Kevin Chen, PharmD, discussed the increase in recent biomarker-driven drug approvals for solid tumors at the 2025 JADPRO Annual Conference, highlighting their targeted efficacy, unique toxicity profiles, and the need for clinicians to stay up...
Kevin Chen, PharmD, discussed the increase in recent biomarker-driven drug approvals for solid tumors at the 2025 JADPRO Annual Conference, highlighting their targeted efficacy, unique toxicity profiles, and the need for clinicians to stay up...
Kevin Chen, PharmD, discussed...
12/17/2025
Oncology Learning Network NP/PA Institute

Visit Our Other APP Institutes

Oncology Learning Network NP/PA Institute logo

The NP/PA Institute is a new offering from the Oncology Learning Network that provides microburst education to oncology advanced practitioners. The platform offers year-round digital non-accredited learning modules through animated short videos, multimedia interviews with key opinion leaders, interactive content to test your knowledge, and more!

 

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use